Israeli -
Kiingereza -
Ministry of Health
mabthera 1400 mg s.c.
roche pharmaceuticals (israel) ltd - rituximab - solution for injection - rituximab 1400 mg / 11.7 ml - rituximab - mabthera subcutaneous formulation is indicated in adults for non-hodgkin`s lymphoma (nhl):• mabthera is indicated for the treatment of previously untreated patients with stage iii-iv follicular lymphoma in combination with chemotherapy.• mabthera maintenance therapy is indicated for the treatment of follicular lymphoma patients responding to induction therapy.• mabthera is indicated for the treatment of patients with cd20 positive diffuse large b cell non-hodgkin’s lymphoma in combination with chop (cyclophosphamide, doxorubicin, vincristine, prednisolone) chemotherapy.
Japani -
Kiingereza -
すりの適正使用協議会 RAD-AR Council, Japan
rituximab bs intravenous infusion 100mg "pfizer" (リツキシマブbs点滴静注100mg「ファイザー」)
pfizer pharmaceuticals inc. - rituximab (genetical recombination) [rituximab biosimilar 2] - injection
Japani -
Kiingereza -
すりの適正使用協議会 RAD-AR Council, Japan
rituximab bs intravenous infusion 500mg "pfizer" (リツキシマブbs点滴静注500mg「ファイザー」)
pfizer pharmaceuticals inc. - rituximab (genetical recombination) [rituximab biosimilar 2] - injection
Japani -
Kiingereza -
すりの適正使用協議会 RAD-AR Council, Japan
rituximab bs intravenous infusion 100mg "khk" (リツキシマブbs点滴静注100mg「khk」)
kyowa kirin co.,ltd - rituximab (genetical recombination) [rituximab biosimilar 1] - injection
Japani -
Kiingereza -
すりの適正使用協議会 RAD-AR Council, Japan
rituximab bs intravenous infusion 500mg "khk" (リツキシマブbs点滴静注500mg「khk」)
kyowa kirin co.,ltd - rituximab (genetical recombination) [rituximab biosimilar 1] - injection
Uingereza -
Kiingereza -
MHRA (Medicines & Healthcare Products Regulatory Agency)
rituximab (mabthera) 1000mg/500ml in sodium chloride 0.9% infusion bags
mabthera) 1000mg/500ml in sodium chloride 0.9% infusion bags (special order - rituximab - infusion - 2mg/1ml
Uingereza -
Kiingereza -
MHRA (Medicines & Healthcare Products Regulatory Agency)
rituximab (truxima) 1000mg/500ml in sodium chloride 0.9% infusion bags
truxima) 1000mg/500ml in sodium chloride 0.9% infusion bags (special order - rituximab - infusion - 2mg/1ml
Uingereza -
Kiingereza -
MHRA (Medicines & Healthcare Products Regulatory Agency)
rituximab (rixathon) 1000mg/500ml in sodium chloride 0.9% infusion bags
rixathon) 1000mg/500ml in sodium chloride 0.9% infusion bags (special order - rituximab - infusion - 2mg/1ml
Uingereza -
Kiingereza -
MHRA (Medicines & Healthcare Products Regulatory Agency)
rituximab (mabthera) 500mg/500ml in sodium chloride 0.9% infusion bags
mabthera) 500mg/500ml in sodium chloride 0.9% infusion bags (special order - rituximab - infusion - 1mg/1ml
Uingereza -
Kiingereza -
MHRA (Medicines & Healthcare Products Regulatory Agency)
rituximab (rixathon) 500mg/500ml in sodium chloride 0.9% infusion bags
rixathon) 500mg/500ml in sodium chloride 0.9% infusion bags (special order - rituximab - infusion - 1mg/1ml